Research Snapshot: Researchers identify genes that predict pediatric AML outcomes
The findings could help develop new treatments to overcome resistance to chemotherapy.
The findings could help develop new treatments to overcome resistance to chemotherapy.
Using patients’ own genetics to tailor their chemotherapy regimens appears to improve outcomes in children with acute myeloid leukemia.
The National Cancer Institute has awarded Jatinder Lamba, Ph.D., M.Sc., a professor of pharmacotherapy and translational research in the University of Florida College of Pharmacy and a member of the UF Health Cancer Center, a five-year, $1.9 million grant titled, “Genomics of AML Prognosis,” to continue research on Acute Myeloid Leukemia, or AML, that began in 2008.